Yuchun Han
Neurology · Chattanooga, TNNPI 1053307041
Payments from drug & device makers
Across 1,224 payments — averaging $40.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$25K
- Biohaven Pharmaceuticals, Inc.$5K
- UCB, Inc.$2K
- Neurelis, Inc.$2K
- Sunovion Pharmaceuticals Inc.$1K
- Teva Pharmaceuticals USA, Inc.$1K
- plus $13K from 48 others
What the payments were for
- Speaking & faculty fees$27,07554%
- Travel & lodging$1,1342%
- Food & beverage$21,84944%
- Education$940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$23,761
- NURTEC ODT$4,625
How this compares
$50,153 in reported general payments places this provider in the 80th percentile of 361 neurology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZeposiaOzanimod Hydrochloride | 13 | $115,568 |
| AptiomEslicarbazepine Acetate | 71 | $94,051 |
| Nurtec OdtRimegepant Sulfate | 50 | $81,046 |
| ValtocoDiazepam | 29 | $71,243 |
| AustedoDeutetrabenazine | 13 | $63,978 |
| BotoxOnabotulinumtoxina | 42 | $52,775 |
| BriviactBrivaracetam | 27 | $27,730 |
| UbrelvyUbrogepant | 17 | $23,981 |
| VraylarCariprazine Hcl | 14 | $19,219 |
| NayzilamMidazolam | 12 | $16,067 |
| FycompaPerampanel | 18 | $15,193 |
| XcopriCenobamate | 12 | $13,794 |
| OzempicSemaglutide | 14 | $12,411 |
| NamzaricMemantine Hcl/Donepezil Hcl | 21 | $12,141 |
| Levetiracetam | 219 | $7,458 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| E.r. Squibb & Sons, L.L.C.Zeposia | $191 | $115,56813 claims |
| AbbVieBotox, Ubrelvy, Vraylar, Namzaric | $25,123 | $108,11694 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $1,360 | $94,05171 claims |
| PfizerNurtec Odt | $185 | $81,04650 claims |
| Neurelis, Inc.Valtoco | $1,802 | $71,24329 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $1,318 | $63,97813 claims |
| UCB, Inc.Briviact, Nayzilam | $2,495 | $43,79639 claims |
| Eisai Inc.Fycompa | $766 | $15,19318 claims |
| SK Life Science, Inc.Xcopri | $802 | $13,79412 claims |
| Upsher-smith Laboratories LLCTopiramate | $895 | $1,115183 claims |
| Almatica Pharma LLCSertraline Hcl | $13 | $23337 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 361 neurology providers in Tennessee.
Other neurology in Chattanooga
- Thomas DevlinChattanooga$288K
- David RankineChattanooga$167K
- Tareck KadrieChattanooga$150K
- Lee SteinCordova$22.6M
- Sibyl WrayKnoxville$21.6M
- Lora McGillMemphis$7.5M
- Thomas ArnoldCordova$5.5M
- Daniel ClaassenNashville$3.5M
- Samuel HunterSpring Hill$2.9M
- Randall TrudellKnoxville$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.